|[January 28, 2014]
Research and Markets: 2014 Report on the US Predictive Breast Cancer Gene Testing Industry
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/m72m99/medipoint)
has announced the addition of the "2014
Report on the US Predictive Breast Cancer Gene Testing Industry"
report to their offering.
The incidence of breast cancer is increasing due to the increased life
span and increasing adoption of Western lifestyle risk factors.
Predictive breast cancer gene tests can be used to identify women who
are at increased risk of developing hereditary breast cancer. The
Predictive Breast Cancer Gene Testing market has seen exponential growth
in the US, dominated by Myriad Genetics.
Gene testing in Europe is mostly carried out by the state funded health
sector, but increasingly private companies are offering breast cancer
gene tests to physicians. Myriad Genetics' position in the market is
dependent on it being the leading provider of the most common breast
An overview of Breast Cancer, which includes epidemiology, etiology,
symptoms, diagnosis, pathology and treatment guidelines.
Annualized US Breast Cancer Gene Testing market revenue and future
forecasts from 2009 to 2011, forecast for 7 years to 2018.
Investigation of current and future market competition for Breast
Cancer Gene Testing
Insightful review of the key industry drivers, restraints and
challenges as well as predicted impact of key events.
Competitor assessment including device approval analysis and device
Marketed and pipeline product profiles covering efficiency, safety,
clinical study details, device approvals, product positioning and
device sales forecast.
Analysis of unmet needs within the market and opportunities for future
Technology trends evaluation to assess strength of pipeline.
An overview of all devices in development including clinical study
details, design and material selection considerations, efficacy
reports, and device approval timelines.
Key Topics Covered:
1 Tables & Figures
3 Disease Overview
4 Competitive Assessment
5 Unmet Needs
6 Pipeline Products
7 Industry Overview
8 Current and Future Players
9 Market Drivers, Opportunities and Barriers
10 US Outlook and Forecasts
Navigenics (now Life Technologies)
For more information visit http://www.researchandmarkets.com/research/m72m99/medipoint
[ Back To TMCnet.com's Homepage ]